Subscribe To
Veeva systems: best of breed with a very wide moat
Veeva Systems has built one of the widest moats in the software industry given the company's dominance of the mission critical ...
May 19, 2022, 5:04 am
What price will the supply chain pay for resiliency?
At one time, a factory in Denmark run by pharmaceutical firm Novo Nordisk A/S (ADR: NVO) made half of t...
May 18, 2022, 5:39 pm
Why tonix pharmaceuticals continued to plummet today
A spot of potentially good news can't stop the investor exodus from the biotech stock....
May 18, 2022, 5:23 pm
Cingulate to present at h.c. wainwright global investment conference
KANSAS CITY, Kan., May 18, 2022 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a clinical-stage biopharmac...
May 18, 2022, 5:20 pm
Why shares of endo international plummeted 69% on wednesday
Reports that the specialty pharmaceutical company is looking to restructure debt prompted the drop....
May 18, 2022, 4:45 pm
Veru stock alert: 6 things to know as veru appoints a new executive
Veru (VERU) stock is on the move Wednesday following news of the biopharmaceutical company adding Joel ...
May 18, 2022, 10:45 am
Fortress biotech to participate in two upcoming may 2022 investor conferences
MIAMI, May 18, 2022 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative bio...
May 18, 2022, 8:30 am
Aptinyx to participate in h.c. wainwright global investment conference
EVANSTON, Ill.--(BUSINESS WIRE)--Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical compan...
May 18, 2022, 7:37 am
Macrogenics to participate in upcoming investor conference
ROCKVILLE, MD, May 17, 2022 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical c...
May 17, 2022, 4:01 pm
Cardiol therapeutics receives us fda authorization for phase ii study of cardiolrx for recurrent pericarditis
Cardiol Therapeutics (TSX:CRDL, NASDAQ:CRDL) Inc announced that the US Food and Drug Administration has authorized its Investigational New Drug Applic...
May 17, 2022, 10:07 am
Catalyst pharmaceuticals to participate in two upcoming investor conferences
CORAL GABLES, Fla., May 17, 2022 (GLOBE NEWSWIRE) -- Catalyst pharmaceuticals, Inc. ("Catalyst") (Nasda...
May 17, 2022, 8:03 am
Diffusion pharmaceuticals to present at h.c. wainwright global investment conference
CHARLOTTESVILLE, Va., May 17, 2022 (GLOBE NEWSWIRE) -- Diffusion pharmaceuticals Inc. (NASDAQ: DFFN) (�...
May 17, 2022, 7:30 am
Acumen pharmaceuticals, inc. (abos) ceo daniel o'connell on q1 2022 results - earnings call transcript
Acumen pharmaceuticals, Inc. (NASDAQ:ABOS ) Q1 2022 Earnings Conference Call May 16, 2022 4:30 PM ET Co...
May 16, 2022, 10:27 pm
Adamis pharmaceuticals corporation (admp) ceo dennis carlo on q1 2022 results - earnings call transcript
Adamis pharmaceuticals Corporation (NASDAQ:ADMP ) Q1 2022 Earnings Conference Call May 16, 2022 5:00 PM...
May 16, 2022, 9:28 pm
Ayala pharmaceuticals, inc. (ayla) reports q1 loss, misses revenue estimates
Ayala pharmaceuticals, Inc. (AYLA) delivered earnings and revenue surprises of 7.04% and 57.99%, respec...
May 16, 2022, 6:48 pm
Dynavax to present at the h.c. wainwright global investment conference
EMERYVILLE, Calif. , May 16, 2022 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage bio...
May 16, 2022, 4:10 pm
Lumos pharma to participate in upcoming investor conferences
AUSTIN, Texas, May 16, 2022 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmac...
May 16, 2022, 4:05 pm
Impel pharmaceuticals inc. (impl) reports q1 loss, tops revenue estimates
Impel pharmaceuticals Inc. (IMPL) delivered earnings and revenue surprises of -8.33% and 9.94%, respect...
May 16, 2022, 11:17 am
After plunging 45.5% in 4 weeks, here's why the trend might reverse for pieris pharmaceuticals (pirs)
The heavy selling pressure might have exhausted for Pieris pharmaceuticals (PIRS) as it is technically ...
May 16, 2022, 11:17 am
Tracon pharmaceuticals to present at the h.c. wainwright global investment conference
SAN DIEGO, May 16, 2022 (GLOBE NEWSWIRE) -- TRACON pharmaceuticals (Nasdaq: TCON), a clinical stage bio...
May 16, 2022, 8:05 am